ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0293

Contraction of the Stool Taxa Clostridia Is Associated with the Development of Clinical Disease Among Anti-Ro+ Mothers of Children with Neonatal Lupus

Robert Clancy1, Miranda Marion2, Peter Izmirly3, Mala Masson4, Hannah Ainsworth2, Timothy Howard5, Jill Buyon6 and Carl Langefeld7, 1NYU School of Medicine, New York, 2Wake Forest School of Medicine, Winston-Salem, 3Department of Medicine, New York University School of Medicine, New York, NY, 4New York University School of Medicine, New York, 5Wake Forest School of Medicine, Winston-Salem, NC, 6Department of Medicine, NYU School of Medicine, New York, NY, 7Wake Forest School of Medicine, Winston Salem, NC

Meeting: ACR Convergence 2020

Keywords: Autoantibody(ies), microbiome, Sjögren's Syndrome, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Friday, November 6, 2020

Title: SLE – Etiology & Pathogenesis Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Anti-Ro autoantibody production often precedes the development of systemic lupus erythematosus (SLE) or Sjögren’s syndrome (SS) by years. Anti-Ro+ mothers of children with manifestations of neonatal lupus such as congenital heart block are a unique cohort at risk for pathologic autoimmunity; many are asymptomatic or have an undifferentiated autoimmune syndrome with vague symptoms (Asym/UAS) and become aware of autoantibodies solely based on identification of disease in the fetus or infant.  Over time, a third may progress to established diseases such as SLE or SS (SS/SLE).  This study was initiated to investigate the hypothesis that stool microbiome compositional variation and taxa-specific interactions with class II HLA alleles may correlate with transition to SS/SLE.

Methods: The stool microbiome of 125 anti-Ro+ women (Asym/UAS, N=43; SS/SLE, N=82) and 23 healthy controls (HC) were 16S ribosomal RNA sequenced and assigned to taxa (SILVA). At each taxonomic level, the ranks of the centered log ratio transformed relative abundances were compared, adjusting for batch, to test for differences among groups (HC vs. Asym/UAS vs. SS/SLE); false discovery rate (FDR) adjusted p-values were computed. Class II HLA at DRB1 and DQB1 four-digit alleles were assigned by imputation (HIBAG) or sequencing and tested for an interaction between FDR-significant genera and HLA allele (cumulative logit models).

Results: There were reductions in genera and species diversity (Shannon Index) for the SS/SLE patients (g. 2.62±0.53; spp. 2.36±0.43) compared to Asym/UAS (g. 2.74±0.44; spp. 2.53±0.43) and HC (g. 2.77±0.36; spp 2.50±0.52) (p< 0.05). There were also differences in the microbial relative abundances among the three groups. Of note, the majority (76.9%) of taxa with significant differences among the three groups were in the class Clostridia, which includes the genera Romboutsia and Coprococcus 3. Specifically, by ranking the conditions by disease severity (HC < Asym/UAS < SS/SLE), there was a reduction in the relative abundance of Romboutsia and Coprococcus 3 (P=2.38E-06 and P=1.58E-3, respectively). Given the overall sample size, HLA allelic frequencies and genus-HLA allele interactions (i.e., differential effect of genus depending on which HLA allele was present) were not significant (FDR P >0.05).  However, notable findings include the allele frequencies of the DQB1*0602 allele in Asym/UAS, SS/SLE and HC were 22%, 17% and 10%, respectively (P=0.03). DQB1*0602 taxa by HLA-genus interaction analysis revealed that 70% of the top 20 taxa were contained within Clostridia, including Romboutsia and the 5 taxa below. Suggestive interactions between taxa within Clostridia and DQB1*0602 were Lachnospiraceae UCG-010 (OR=0.52, P=0.006), Oscillibacter (OR=0.57, P=0.01), Intestinimonas (OR=0.60, P=0.02) and Lachnospiraceae_NK4A136 (OR=0.65, P=0.03), and Anaerotruncus (OR=0.61, P=0.05).

Conclusion: Given Clostridia’s critical role in gut homeostasis, including immune functions, reductions in this taxa combined with autoimmune related HLA alleles may serve as harbingers of a shift toward a pathologic gut microbiome that may, in part, explain progression from benign to pathologic autoimmunity and overt SLE and/or SS.


Disclosure: R. Clancy, None; M. Marion, Lupus Research Alliance, 2; P. Izmirly, GSK, 5; M. Masson, None; H. Ainsworth, None; T. Howard, None; J. Buyon, None; C. Langefeld, Lupus Research Alliance, 2.

To cite this abstract in AMA style:

Clancy R, Marion M, Izmirly P, Masson M, Ainsworth H, Howard T, Buyon J, Langefeld C. Contraction of the Stool Taxa Clostridia Is Associated with the Development of Clinical Disease Among Anti-Ro+ Mothers of Children with Neonatal Lupus [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/contraction-of-the-stool-taxa-clostridia-is-associated-with-the-development-of-clinical-disease-among-anti-ro-mothers-of-children-with-neonatal-lupus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/contraction-of-the-stool-taxa-clostridia-is-associated-with-the-development-of-clinical-disease-among-anti-ro-mothers-of-children-with-neonatal-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology